Biblio

Found 346 results
2018
Olson KM, Keresztes A, Tashiro JK, Daconta LV, Hruby VJ, Streicher JM.  2018.  Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice.. J Med Chem. 61(14):6075-6086.
Shah N, Kumar S, Zaman N, Pan CC, Bloodworth JC, Lei W, Streicher JM, Hempel N, Mythreye K, Lee NY.  2018.  TAK1 activation of alpha-TAT1 and microtubule hyperacetylation control AKT signaling and cell growth.. Nat Commun. 9(1):1696.
2017
Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, Dhingra D, Cranmer LD, Hurwitz BL.  2017.  16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria.. J Appl Microbiol.
Starnowska J, Costante R, Guillemyn K, Popiolek-Barczyk K, Chung NN, Lemieux C, Keresztes A, Van Duppen J, Mollica A, Streicher J et al..  2017.  Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.. ACS Chem Neurosci.
Pan CC, Shah N, Kumar S, Wheeler SE, Cinti J, Hoyt DG, Beattie CE, An M, Mythreye K, L Rakotondraibe H et al..  2017.  Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy.. Oncotarget. 8(8):12675-12685.
Nelson MA, Lochhead JD, Maguire GA.  2017.  Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder.. Ann Clin Psychiatry. 29(3):205-206.
Moutal A, Dustrude ET, Largent-Milnes TM, Vanderah TW, Khanna M, Khanna R.  2017.  Blocking CRMP2 SUMOylation reverses neuropathic pain.. Mol Psychiatry.
Abdullahi W, Brzica H, Ibbotson K, Davis TP, Ronaldson PT.  2017.  Bone morphogenetic protein-9 increases the functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier via the activin receptor-like kinase-1 receptor.. J Cereb Blood Flow Metab. 37(7):2340-2345.
Yin F, Yao J, Brinton RD, Cadenas E.  2017.  Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration.. Front Aging Neurosci. 9:209.
Wheeler SE, Lee NY.  2017.  Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy.. J Cell Physiol. 232(3):486-489.
Geifman N, Brinton RDiaz, Kennedy RE, Schneider LS, Butte AJ.  2017.  Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.. Alzheimers Res Ther. 9(1):10.
Stefanucci A, Lei W, Hruby VJ, Macedonio G, Luisi G, Carradori S, Streicher JM, Mollica A.  2017.  Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers.. Future Med Chem. 9(9):859-869.
Abdullahi W, Davis TP, Ronaldson PT.  2017.  Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? AAPS J. 19(4):931-939.
Sandweiss AJ, McIntosh MI, Moutal A, Davidson-Knapp R, Hu J, Giri AK, Yamamoto T, Hruby VJ, Khanna R, Largent-Milnes TM et al..  2017.  Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential.. Mol Psychiatry.
Lei W, Mullen N, McCarthy S, Brann C, Richard P, Cormier J, Edwards K, Bilsky EJ, Streicher JM.  2017.  Heat-shock protein 90 (Hsp90) promotes opioid-induced anti-nociception by an ERK mitogen-activated protein kinase (MAPK) mechanism in mouse brain.. J Biol Chem. 292(25):10414-10428.
Moutal A, Li W, Wang Y, Ju W, Luo S, Cai S, François-Moutal L, Perez-Miller S, Hu J, Dustrude ET et al..  2017.  Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.. Br J Pharmacol.
Lochhead JJ, Ronaldson PT, Davis TP.  2017.  Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.. AAPS J. 19(4):910-920.
Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M et al..  2017.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.. Cephalalgia. 37(8):780-794.
Sharma SV, Tong X, Pubill-Ulldemolins C, Cartmell C, Bogosyan EJA, Rackham EJ, Marelli E, Hamed RB, Goss RJM.  2017.  Living GenoChemetics by hyphenating synthetic biology and synthetic chemistry in vivo. Nature Communication.
Ibrahim MM, Patwardhan A, Gilbraith KB, Moutal A, Yang X, Chew LA, Largent-Milnes T, T Malan P, Vanderah TW, Porreca F et al..  2017.  Long-lasting antinociceptive effects of green light in acute and chronic pain in rats.. Pain. 158(2):347-360.
Olson KM, Lei W, Keresztes A, LaVigne J, Streicher JM.  2017.  Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.. Yale J Biol Med. 90(1):97-110.
Ibbotson K, Yell J, Ronaldson PT.  2017.  Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress.. Fluids Barriers CNS. 14(1):6.
Wang JY, Trivedi AM, Carrillo NR, Yang J, Schneider A, Giulivi C, Adams P, Tassone F, Kim K, Rivera SM et al..  2017.  Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome.. Neurotherapeutics.
Hernandez G, Zhao L, Franke AA, Chen Y-L, Mack WJ, Brinton RD, Schneider LS.  2017.  Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women.. Menopause.
Remesic M, Hruby VJ, Porreca F, Lee YSun.  2017.  Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.. ACS Chem Neurosci. 8(6):1147-1158.

Pages